These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 27975129

  • 1. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J, Hu J, Liu G, Cui Y, Ju Y.
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, Kulesza-Bronczyk B, Kinalski M, Terlikowski SJ.
    Eur Cytokine Netw; 2013 Feb; 24(3):106-13. PubMed ID: 24197277
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X, Müller V, Milde-Langosch K, Trillsch F, Pantel K, Schwarzenbach H.
    Oncotarget; 2016 Mar 29; 7(13):16923-35. PubMed ID: 26943577
    [Abstract] [Full Text] [Related]

  • 4. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
    Yildiz I, Tas F, Kilic L, Sen F, Saip P, Eralp Y, Keskin S, Karabulut S, Ciftci R, Serilmez M, Yasasever V, Aydiner A.
    Cancer Chemother Pharmacol; 2013 Aug 29; 72(2):437-44. PubMed ID: 23801282
    [Abstract] [Full Text] [Related]

  • 5. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul 25; 51(7):515-23. PubMed ID: 27465871
    [Abstract] [Full Text] [Related]

  • 6. Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer.
    Guo X, Liu Y, Huang X, Wang Y, Qu J, Lv Y.
    Cancer Biomark; 2017 Dec 12; 21(1):81-87. PubMed ID: 29060928
    [Abstract] [Full Text] [Related]

  • 7. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
    Rohr I, Braicu EI, En-Nia A, Heinrich M, Richter R, Chekerov R, Dechend R, Heidecke H, Dragun D, Schäfer R, Gorny X, Lindquist JA, Brandt S, Sehouli J, Mertens PR.
    Cytokine; 2016 Sep 12; 85():157-64. PubMed ID: 27371774
    [Abstract] [Full Text] [Related]

  • 8. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer.
    Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P.
    Arch Gynecol Obstet; 2017 Nov 12; 296(5):989-995. PubMed ID: 28875365
    [Abstract] [Full Text] [Related]

  • 9. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
    Li W, Fang C, Gao Y, Gao Y, Yan F, Chen B, Xu M.
    Biotechnol Appl Biochem; 2024 Aug 12; 71(4):733-740. PubMed ID: 38494670
    [Abstract] [Full Text] [Related]

  • 10. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
    Luo Y, Kim HS, Kim M, Lee M, Song YS.
    J Gynecol Oncol; 2017 May 12; 28(3):e36. PubMed ID: 28382799
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
    Yuan L, Wan J, Huang C, Liang J, Liu M, Yue C, Li L.
    Cancer Biomark; 2017 Dec 12; 21(1):97-104. PubMed ID: 29036787
    [Abstract] [Full Text] [Related]

  • 12. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Dec 12; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 13. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M, Khan I, Gandhi G, Ray PC, Saxena A.
    Tumour Biol; 2016 Aug 12; 37(8):11259-66. PubMed ID: 26951510
    [Abstract] [Full Text] [Related]

  • 14. KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
    Huang L, Zhou Y, Cao XP, Lin JX, Zhang L, Huang ST, Zheng M.
    Tumour Biol; 2017 Jun 12; 39(6):1010428317706289. PubMed ID: 28651492
    [Abstract] [Full Text] [Related]

  • 15. Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma.
    Cho HW, Ouh YT, Hong JH, Lee JK.
    Arch Gynecol Obstet; 2021 Mar 12; 303(3):803-810. PubMed ID: 33078229
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W, Niu C, He W, Hou T, Sun X, Xu L, Zhang Y.
    Tumour Biol; 2016 May 12; 37(5):6239-54. PubMed ID: 26615423
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y.
    Med Oncol; 2013 Mar 12; 30(1):324. PubMed ID: 23254963
    [Abstract] [Full Text] [Related]

  • 18. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D, Matte I, Garde-Granger P, Laplante C, Carignan A, Rancourt C, Piché A.
    BMC Cancer; 2015 Jul 01; 15():492. PubMed ID: 26122176
    [Abstract] [Full Text] [Related]

  • 19. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer.
    Xu YZ, Xi QH, Ge WL, Zhang XQ.
    Asian Pac J Cancer Prev; 2013 Jul 01; 14(2):1057-60. PubMed ID: 23621186
    [Abstract] [Full Text] [Related]

  • 20. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
    Sallinen H, Heikura T, Laidinen S, Kosma VM, Heinonen S, Ylä-Herttuala S, Anttila M.
    Int J Gynecol Cancer; 2010 Dec 01; 20(9):1498-505. PubMed ID: 21119365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.